NCT00115128View on ClinicalTrials.gov

Open-Label Trial of Peripheral Blood Progenitor Cell (PBPC) Mobilization by Filgrastim in Normal Donors

CompletedOBSERVATIONAL
Enrollment

309

Participants

Timeline

Start Date

November 30, 2003

Primary Completion Date

May 31, 2007

Study Completion Date

September 30, 2007

Conditions
Normal PBPC Donors
Interventions
DRUG

filgrastim

Normal donors being treated with filgrastim for PBPC mobilization and collection

Sponsors

Lead Sponsor

Amgen
All Listed Sponsors
lead

Amgen

INDUSTRY

NCT00115128 - Open-Label Trial of Peripheral Blood Progenitor Cell (PBPC) Mobilization by Filgrastim in Normal Donors | Biotech Hunter | Biotech Hunter